Delivery Order SPE2DB22D3011-SPE2DB24FQ2CW

Award Date 6/21/24
Potential Completion Date 6/24/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $6,322.56 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of the pharmaceutical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" with a completion date of May 21, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $15,271.60 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" and has a completion date of May 30, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC,...
The U.S. Defense Logistics Agency (DLA) awarded a $1,053.76 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. This delivery order contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a $2,986.80 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4564668271 ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, with a completion date of May 22, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $1,393.14 firm fixed-price contract is for the supply of the pharmaceutical product "ZEPBOUND 10 MG/0.5 ML PEN 0.5ML." This award is under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which enables DLA to efficiently...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $1,388.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period ending on May 13, 2024. This delivery order is issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to...
The Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of pharmaceutical products and medical supplies, including the medication "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML". The contract has a ceiling value of $3,161.28 and a completion date of June 7, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense...
The Defense Logistics Agency (DLA) awarded a $1,053.76 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. This contract is for the provision of the drug "ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML" and does not have a set-aside designation. Amerisourcebergen also holds a larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued up to...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,161.28 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565379461 ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML. This contract has an ultimate completion date of August 8, 2024 and is not set aside. AmerisourceBergen, through its extensive supply chain network, provides a wide range of prescription medications, over-the-counter drugs, and medical supplies to support various...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML." The firm-fixed-price contract has a ceiling value of $1,430.46 and a completion date of May 2, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB24FQ2CW
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,241.34 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which runs through June 2024, is for the supply of the pharmaceutical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML." Amerisourcebergen, a major supplier of pharmaceuticals and medical supplies to the federal government, is providing these products to support DLA Troop Support Medical's mission to procure essential medical commodities for military treatment programs and facilities globally. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract was awarded on a full and open competition basis without any set-aside designation.

Generated 9/20/24, 9:27 AM